Cargando…
Coinhibitory Molecules in Autoimmune Diseases
Coinhibitory molecules such as CTLA-4, PD-1 and BTLA negatively regulate immune responses. Multiple studies indicate that the deficiency or mutation of coinhibitory molecules leads to the development of autoimmune diseases in mice and humans, indicating that the negative signals from coinhibitory mo...
Autores principales: | Watanabe, Norihiko, Nakajima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446788/ https://www.ncbi.nlm.nih.gov/pubmed/22997525 http://dx.doi.org/10.1155/2012/269756 |
Ejemplares similares
-
Influence of T Cell Coinhibitory Molecules on CD8(+) Recall Responses
por: Morris, Anna B., et al.
Publicado: (2018) -
The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019) -
T Cell Costimulatory and Coinhibitory Pathways in Vascular Inflammatory Diseases
por: Lichtman, Andrew H.
Publicado: (2012) -
The Role of Coinhibitory Signaling Pathways in Transplantation and Tolerance
por: McGrath, Martina M., et al.
Publicado: (2012) -
Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules
por: Gannavaram, Sreenivas, et al.
Publicado: (2016)